Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe E Gatt

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Leukemia Research|August 30, 2020
The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life dataIrit Avivi, Moshe E Gatt, Efrat Luttwak, et al.
Annals of Hematology|September 14, 2019
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patientsBoaz Nachmias, Veronica Sandler, Elena Slyusarevsky, et al.
Integrative Cancer Therapies|June 4, 2015
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile NeutropeniaMoshe E Gatt, Jacob Strahilevitz, Nir Sharon, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2020
Neurological misdiagnoses of lymphomaChen Makranz, David Arkadir, Boaz Nachmias, et al.
Leukemia & Lymphoma|January 29, 2019
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapseNeta Goldschmidt, Netanel A Horowitz, Vered Heffes, et al.
Acta Haematologica|January 30, 2025
Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic LeukemiaUriel Oanunu, Noa Gross Even-Zohar, Shlomzion Aumann, et al.
Cancers|November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of InterestBoaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
British Journal of Haematology|October 30, 2013
Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myelomaDavid Azoulay, David Lavie, Netanel Horowitz, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2016
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapyNeta Goldschmidt, Geffen Kleinstern, Marina Orevi, et al.
Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Leukemia Research|August 30, 2020
The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life dataIrit Avivi, Moshe E Gatt, Efrat Luttwak, et al.
Annals of Hematology|September 14, 2019
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patientsBoaz Nachmias, Veronica Sandler, Elena Slyusarevsky, et al.
Integrative Cancer Therapies|June 4, 2015
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile NeutropeniaMoshe E Gatt, Jacob Strahilevitz, Nir Sharon, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 25, 2020
Neurological misdiagnoses of lymphomaChen Makranz, David Arkadir, Boaz Nachmias, et al.
Leukemia & Lymphoma|January 29, 2019
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapseNeta Goldschmidt, Netanel A Horowitz, Vered Heffes, et al.
Acta Haematologica|January 30, 2025
Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic LeukemiaUriel Oanunu, Noa Gross Even-Zohar, Shlomzion Aumann, et al.
Cancers|November 25, 2023
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of InterestBoaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, et al.
British Journal of Haematology|October 30, 2013
Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myelomaDavid Azoulay, David Lavie, Netanel Horowitz, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2016
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapyNeta Goldschmidt, Geffen Kleinstern, Marina Orevi, et al.
Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.
Pageof 9